Cart
sales@molnova.com
Ceclazepide
CAS No. 1801749-44-9
Ceclazepide( Ceclazepide )
Catalog No. M12743 CAS No. 1801749-44-9
A potent, selective cholecystokinin receptor CCK2 antagonist for treatment of gastroesophageal reflux disease (GERD).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1323 | Get Quote |
|
| 50MG | 2682 | Get Quote |
|
| 100MG | 3600 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCeclazepide
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective cholecystokinin receptor CCK2 antagonist for treatment of gastroesophageal reflux disease (GERD).
-
DescriptionA potent, selective cholecystokinin receptor CCK2 antagonist for treatment of gastroesophageal reflux disease (GERD).Other Indication Phase 1 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsCeclazepide
-
PathwayGPCR/G Protein
-
TargetCholecystokinin Receptor
-
RecptorCholecystokinin Receptor
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number1801749-44-9
-
Formula Weight556.623
-
Molecular FormulaC30H32N6O5
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(C)OCC(C)(C)C(CN1C([C@H](NC(NC2=CC=CC(NC)=C2)=O)N=C(C3=NC=CC=C3)C4=CC=CC=C41)=O)=O
-
Chemical Name(R)-2,2-dimethyl-4-(3-(3-(3-(methylamino)phenyl)ureido)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-1-yl)-3-oxobutyl acetate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
GI 181771
GI 181771 is an agonist of the cholecystokinin 1 receptor. GI 181771 can be used in studies about obesity.
-
GV-150013X
GV-150013X ((S)-1-(1-(adamantan-1-ylmethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)-3-phenylurea) is a potent CCKB antiagonist, pKi= 9.02.
-
N-Cbz-DL-tryptophan
N-Cbz-DL-tryptophan is a cholecystokinin receptor antagonist, abolished the response of the isolated heart to CCK-8.
